Envelope gene-mediated neurovirulence in feline immunodeficiency virus infection: Induction of matrix metalloproteinases and neuronal injury

Journal of Virology

Volumn 76, Issue 6, 2002, Pages 2622-2633

  Johnston, J B ^a   Silva, C ^a   Power, C ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; MATRIX METALLOPROTEINASE; NEUROTOXIN; PRINOMASTAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTOSIS; CAT; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENVELOPE GENE; FELINE IMMUNODEFICIENCY VIRUS; FEMALE; GENETIC VARIABILITY; IMMUNOREACTIVITY; LENTIVIRINAE; MACROPHAGE ACTIVATION; NERVE INJURY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS INFECTION; VIRUS VIRULENCE;

ANIMALS; ANIMALS, NEWBORN; BRAIN; CATS; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GENES, ENV; HUMANS; IMMUNODEFICIENCY VIRUS, FELINE; INFANT, NEWBORN; LENTIVIRUS INFECTIONS; MACROPHAGES; MATRIX METALLOPROTEINASES; MICE; NEURONS; PREGNANCY; TUMOR CELLS, CULTURED; VIRAL ENVELOPE PROTEINS; VIRULENCE;

EID: 0036187844     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.6.2622-2633.2002     Document Type: Article

References (62)

1. Genetic diversity of feline immunodeficiency virus: Dual infection, recombination, and distinct evolutionary rates among envelope sequence clades
2. Feline immunodeficiency virus: An interesting model for AIDS studies and an important cat pathogen
3. Microglial activation and neurological symptoms in the SIV model of NeuroAIDS: Association of MHC-II and MMP-9 expression with behavioral deficits and evoked potential changes
4. Replication rate of feline immunodeficiency virus in astrocytes is envelope dependent: Implications for glutamate uptake
5. Virus load and neuropathology in the FIV model
6. Neurotoxicity of FIV and FIV envelope protein in feline cortical cultures
7. Identity of neurotrophic molecules released from astroglia by vasoactive intestinal peptide
8. Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys
9. Macrophagetropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: Definition of critical amino acids involved in cell tropism
10. Development of a quasispecies of human immunodeficiency virus type 1 in vivo
11. Genomic changes associated with antigenic variation of visna virus during persistent infection
12. Cerebrospinal fluid levels of MMP-2, -7, and -9 are elevated in association with human immunodeficiency virus dementia
13. Transcriptional inhibition of matrix metalloproteinase 9 (MMP-9) activity by a c-fos/estrogen receptor fusion protein is mediated by the proximal AP-1 site of the MMP-9 promoter and correlates with reduced tumor cell invasion
14. HIV infection of macrophages and pathogenesis of AIDS dementia complex: Interaction of the host cell and viral genotype
15. Feline immunodeficiency virus: A neurotropic lentivirus
16. Inhibition of matrix metalloproteinase MMP-2 activates chloride current in human airway epithelial cells
17. Matrix metalloproteinases and processing of pro-TNF-α
18. Early brain injury in the SIV-macaque model of AIDS
19. Association of c-fos mRNA expression and excitotoxicity in primary cultures of mouse neocortical and cerebellar neurons
20. Neurotoxic effects of feline immunodeficiency virus, FIVPPR
21. Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment
22. Roles of the auxiliary genes and AP-1 binding site in the long terminal repeat of feline immunodeficiency virus in the early stage of infection in cats
23. Productive infection of human peripheral blood mononuclear cells by feline immunodeficiency virus: Implications for vector development
24. Lentivirus infection in the brain induces matrix metalloproteinase expression: Role of envelope diversity
25. HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors
26. Differences among HIV-1 variants in their ability to elicit secretion of TNF-α
27. Genomic variation and segregation of equine infectious anemia virus during acute infection
28. Activation of progelatinase A and progelatinase A/TIMP-2 complex by membrane type 2-matrix metalloproteinase
29. The effects of the HIV-1 envelope protein gp120 on the production of nitric oxide and proinflammatory cytokines in mixed glial cell cultures
30. Expanded host cell tropism and cytopathic properties of feline immunodeficiency virus strain PPR subsequent to passage through interleukin-2-independent T cells
31. Pathogenesis of simian immunodeficiency virus encephalitis: Viral determinants of neurovirulence
32. The AP-1 binding site in the feline immunodeficiency virus long terminal repeat is not required for virus replication in feline T lymphocytes
33. Activation mechanisms of matrix metalloproteinases
34. Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: Protection by memantine
35. Expression of c-fos, c-jun, and c-jun N-terminal kinase (JNK) in a developmental model of induced apoptotic death in neurons of the substantia nigra
36. Differences in feline immunodeficiency virus host cell range correlate with envelope fusogenic properties
37. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome
38. Neurological abnormalities associated with feline immunodeficiency virus infection
39. Progressive encephalopathy associated with CD4/CD8 inversion in adult FIV-infected cats
40. Tumor necrosis factor-alpha and virus expression in the central nervous system of cats infected with feline immunodeficiency virus
41. Neurovirulence in feline immunodeficiency virus-infected neonatal cats is viral strain specific and dependent on systemic immune suppression
42. Distinct HIV-1 env sequences are associated with neurotropism and neurovirulence
43. Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients
44. Feline immunodeficiency virus causes increased glutamate levels and neuronal loss in brain
45. Feline immunodeficiency virus envelope protein (FIV gp120) causes electrophysiological alterations in rats
46. Matrix metalloproteinases in brain injury
47. Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials
48. Infection of primary human microglia and monocyte-derived macrophages with human immunodeficiency virus type 1 isolates: Evidence of differential tropism
49. In vivo and in vitro infection with two different molecular clones of visna virus
50. The possible role of c-fos expression in rheumatoid cartilage destruction
51. Glioma invasion in vitro: Regulation by matrix metalloproteinase-2 and protein kinase C
52. Envelope gene sequences encoding variable regions 3 and 4 are involved in macrophage tropism of feline immunodeficiency virus
53. A single amino acid substitution in the transmembrane envelope glycoprotein of feline immunodeficiency virus alters cellular tropism
54. A single mutation within the V3 envelope neutralization domain of feline immunodeficiency virus determines its tropism for CRFK cells
55. Animal models recapitulate aspects of HIV/CNS disease
56. Cytotoxicity by matrix metalloprotease-1 in organotypic spinal cord and dissociated neuronal cultures
57. Processing and release of tumor necrosis factor alpha
58. Neuropathogenesis of simian immunodeficiency virus in neonatal rhesus macaques
59. The role of the chemokine receptor CXCR4 in infection with feline immunodeficiency virus
60. Matrix metalloproteinases and diseases of the CNS
61. Effects of feline immunodeficiency virus on astrocyte glutamate uptake: Implications for lentivirus-induced central nervous system diseases
62. Cellular mechanisms of feline immunodeficiency virus (FIV)-induced neuropathogenesis